Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Molecular Insight Pharmaceuticals, Inc
Finance & Acquisitions: Molecular Insights
IPO (2007)

SenoRx

Parents

*Architects: Surgical Technology_Minimally Invasive & Natural Orifice Transluminal Endoscopic Surgery (NOTES) Technology
*Pioneers: Cancer_ Breast
*Portfolio Companies: Domain
IPO (2007)

17 products that have already received FDA 510(k) clearance across the continuum of breast care
A total of 13 granted national patents from eight different European countries.
Aliso Viejo, California 92656
Design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer.
Founded 1989
In addition, SenoRx has 66 pending United States patent applications and 19 pending European patent applications
Primarily relating to breast biopsy, including biopsy site marking devices, excision devices, and balloon products
SenoRx has a strong portfolio of intellectual property.
Surgical tools for breast disease
The company currently has 43 issued United States patents